Protocol # M11-602: A Blinded, Randomized, Placebo-controlled, Dose Ranging Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-450 with Ritonavir (ABT-450/r) ABT-333 or ABT-072 Each Administered A

Project: Research project

Project Details

StatusFinished
Effective start/end date12/10/098/31/13

Funding

  • Abbott Laboratories (Protocol # M11-602)